top of page

What's new in MedTech & HealthTech (September)

Welcome to our latest blog, curated by our Director, Josh Crave, at our executive recruitment company specialising in the MedTech and HealthTech sectors. In this edition, we have compiled the industry's most recent news and developments, including launching an innovative arthritis pain management program, prestigious awards in the healthcare business, regulatory reform calls, and notable industry investments. Stay informed about advancements and opportunities within the MedTech and HealthTech sectors by exploring the headlines and links below.

Wellmind Health Launches Pathway through Arthritis Program.

Wellmind Health has officially launched Pathway through Arthritis, an arthritis pain management program developed in collaboration with the UK charity Versus Arthritis. Unveiling the platform at the HETT Show in London. Read more


Medilink North Opens Entries for the 2024 Healthcare Business Awards

The Medilink Healthcare Business Awards is an annual event that highlights and celebrates innovations in the medtech sector across North England. The 2024 competition offers another opportunity for life sciences companies to demonstrate successful collaborations and showcase their talent within the area. The event also marks the 10th year of sponsorship from various AHSNs. Read more


MedTech Europe Calls for Structural Reform of European Regulation

MedTech Europe has sent an open letter to European Commissioner for Health Stella Kyriakides. The letter, signed by 34 national associations, calls for comprehensive structural reform in the European regulatory framework for medical technologies (IVDR and MDR). Read more


Ibex Medical Analytics Secures $55 Million in Series C Financing.

Ibex Medical Analytics, an AI-powered cancer diagnostics company, closed a $55 million Series C financing round led by 83North, with participation from Sienna Venture Capital and existing investors. Read more


Global Software as a Medical Device (SaMD) Market Expanded in 2020

SaMD, software that performs medical functions, has seen market growth in 2020. The most significant proportion of the market share is cloud-based, taking about 67.34% of the global market. The primary use of SaMD is for monitoring and alerting, with a proportion of approximately 41.55% in 2020. Read more

20 views0 comments


bottom of page